About Us
Put the power of Bio-M Technology™ to work for you
We have worked with our clients to develop: enhanced GLP-1 and GLP-1/GIP ODTs and Capsules, Type 2 diabetes control, lipid modulation (balancing lipid profile). We are currently working with clients in phase 3 trials for Atherosclerosis and congestive heart failure (CHF). Combining Bio-M Technology™ with your drug and/or nutraceutical development will improve its efficacy and lower negative side effects. To take your research and development to the next level reach out and see how Bio-M Technology™ powers your drug development.
GLP-1/GIP Peptides
Our AMCT enhanced Oral GLP-1 tablets have efficacy with micro dose levels as low as 0.035mg per dose. All other GLP-1 tablets have doses exceeding 25mg per dose due to peptide degradation in the stomach (95% plus destroyed). Bio-M Technology™ bypasses the digestive tract and is rapidly absorbed before the peptides are damaged.
Partnership
Zoom Biotech brings a full compliment of researchers, consultants and clinical trial teams to help your next product development be a success. Whether you are in the Pharmaceutical or Nutritional space Bio-M Technology™ will elevate your products above the competition.